01/29/2018

What do all the opioid bills mean for my practice??

On December 27, 2017, Lt. Gov. Brian Calley signed legislation addressing the opioid epidemic our country is facing.  Below are the key take away points from each bill.       

SB 166, 167 - Public Acts 248, 249 of 2017

• Click here to view the Legislative Analysis
• Require prescribers to check MAPS prior to providing controlled substances, for more than 3 day supply.  Effective June 1, 2018; requires registration with MAPS by June 1, 2018.
• Not applicable to dispensing/administering in freestanding outpatient facility.
• Disciplinary actions for failure to comply.

SB 270 - Public Act 247 of 2017

• Click here to view the Legislative Analysis
• Requires bona-fide physician-patient relationship; requires certain follow up care or referral for follow up care.
• Provides for rule promulgation by LARA, in consultation with various medical licensure boards, for exceptions to bona-fide relationship within one year of the bill's effective date of December 27, 2017.
• Sanctions for failure to comply.

SB 273 - Public Act 250 of 2018

• Click here to view the Legislative Analysis
• Requires health professionals to provide information on substance abuse treatment services to patients who have experienced an overdose. 
• Effective date March 27, 2018.

SB 274 - Public Act 251 of 2018

• Click here to view the Legislative Analysis
• Allow a pharmacist to partially fill a prescription for Schedule 2 controlled substance.
• Limits a prescriber from prescribing more than a 7 day supply of an opioid within a 7 day period; acute pain is defined as pain that is the normal, physiological response to a noxious chemical or a thermal or mechanical stimulus and is typically associated with invasive procedures, trauma, and disease and usually lasts for a limited amount of time. 
• Effective date March 27, 2018
• ** Note to oncologists: it was recommended to put the ICD-10 code for "neoplasm related pain" on pain scripts, if you don't already do so.

SB 47 - Public Act 252 of 2017

• Click here to view the Legislative Analysis 
• Revises exemptions from MAPS reporting for a hospital dispensing a controlled substance to an inpatient; a licensed health facility or agency dispensing a 2 or less day supply.
• Requires a prescriber to review patient data on MAPS before dispensing or prescribing buprenorphine or a drug containing buprenorphine to a patient in a substance use disorder program.  Requires prescriber to report prescribing or dispending these medicine as long as federal law permits. 
• Effective March 27, 2018.

House Bill 4408 - Public Act 246 of 2017

• Click here to view the Legislative Analysis
• Requires prescriber to provide information about opioid addiction and proper disposal of controlled substances. 
• Effective June 1, 2018.

House Bill 4403 - Public Act 253 of 2017

• Click here to view the Legislative Analysis
• Codifies treatment options for Medicaid beneficiaries, including medically necessary treatment, inpatient care and clinical stabilization. 
• Effective March 27, 2018.

House Bill 4406 - Public Act 254 of 2017

• Click here to view the Legislative Analysis
• Requires the Prescription Drug and Opioid Abuse Commission to develop recommendations for how to instruct students on prescription drug abuse and addiction. 
• Effective March 27, 2018.

House Bill 4407 - Public Act 255 of 2017

• Click here to view the Legislative Analysis
• Requires schools to include education on opioids and the potential for addiction in health education curricula. 
• Effective March 27, 2018

We ask that our members keep tabs on how these laws affect your practice and work flow.  Please contact the MSHO office with your concerns.  You can reach our office by calling 248-385-5464 or emailing mmakarewicz@msho.org.